Group One Trading
PSTX

Group One Trading’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Group One Trading’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,300
Closed -$128K – 8606
2024
Q4 		$128K Sell
13,300
-10,900
-45% -$56.9K ﹤0.01% 4312
2024
Q3 		$69.2K Sell
24,200
-100
-0.4% -$310 ﹤0.01% 4434
2024
Q2 		$71K Buy
24,300
+5,800
+31% +$15.9K ﹤0.01% 4247
2024
Q1 		$59K Buy
18,500
+16,600
+874% +$55.4K ﹤0.01% 4583
2023
Q4 		$6.38K Sell
1,900
-5,300
-74% -$13.7K ﹤0.01% 6418
2023
Q3 		$17.1K Sell
7,200
-6,600
-48% -$13.8K ﹤0.01% 5997
2023
Q2 		$24.3K Buy
13,800
+2,300
+20% +$5.88K ﹤0.01% 5845
2023
Q1 		$35.4K Sell
11,500
-6,600
-36% -$39.6K ﹤0.01% 5114
2022
Q4 		$95.9K Buy
18,100
+17,600
+3,520% +$80.5K ﹤0.01% 4478
2022
Q3 		$2K Sell
500
-600
-55% -$1.98K ﹤0.01% 7223
2022
Q2 		$3K Hold
1,100
– – ﹤0.01% 7337
2022
Q1 		$5K Buy
+1,100
New +$4.96K ﹤0.01% 7486

Other funds holding PSTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Group One Trading's PSTX Position: Q1 2025 in Review

Group One Trading sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 5,235 shares — an estimated $50.3K sold.

Group One Trading first reported a position in PSTX in Q3 2022 and held it in 6 quarters. The position peaked at $50.3K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

  • Group One Trading reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Group One Trading sold 5,235 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $50.3K.
  • Group One Trading first reported a position in Poseida Therapeutics, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
  • Group One Trading's Poseida Therapeutics, Inc. Common Stock position peaked at $50.3K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.